indolent lymphoma | Mantle cell lymphoma
Item
patients with histologically or cytologically confirmed indolent lymphoma (including mantle cell lymphoma)
boolean
C1334170 (UMLS CUI [1])
C0334634 (UMLS CUI [2])
Measurable Disease Major Axis size | X-Ray Computed Tomography
Item
patients with measurable lesions (major axis > 1.5 cm by ct)
boolean
C1513041 (UMLS CUI [1,1])
C1295723 (UMLS CUI [1,2])
C0456389 (UMLS CUI [1,3])
C0040405 (UMLS CUI [2])
Prior Chemotherapy partial response failed | antibody therapy partial response failed | Subsequent Relapse Post complete remission | Subsequent Relapse Post partial response
Item
patients who failed to have pr to previous chemotherapies or antibody therapies. patients with subsequent relapse after a previously attained cr or with subsequent recurrence after a previously attained pr
boolean
C1514457 (UMLS CUI [1,1])
C1521726 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0281176 (UMLS CUI [2,1])
C1521726 (UMLS CUI [2,2])
C0231175 (UMLS CUI [2,3])
C4053982 (UMLS CUI [3,1])
C0687676 (UMLS CUI [3,2])
C0677874 (UMLS CUI [3,3])
C4053982 (UMLS CUI [4,1])
C0687676 (UMLS CUI [4,2])
C1521726 (UMLS CUI [4,3])
Chemotherapy | antibody therapy | Therapeutic radiology procedure
Item
patients who have not received chemotherapies, antibody therapies or radiotherapies for more than 4 weeks (more than 3 months in the case of the antibody therapies)
boolean
C0392920 (UMLS CUI [1])
C0281176 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
ECOG performance status
Item
patients who have ps grade 0 to 2 in the criteria of ecog
boolean
C1520224 (UMLS CUI [1])
organ function
Item
patients with adequately maintained organ functions
boolean
C0678852 (UMLS CUI [1])
Communicable Disease | Complication Serious | Gastrointestinal symptom Serious | Bleeding tendency Serious | Disseminated Intravascular Coagulation | CNS metastases | Fever | Pneumonia, Interstitial | Pulmonary Fibrosis | Malignant Neoplasms | Autoimmune hemolytic anemia | Hypersensitivity Purine analog
Item
patients with infectious disease, serious complications, serious gastrointestinal symptoms, serious bleeding tendency (dic), cns metastases, fever more than 38 degrees celsius, interstitial pneumonia or pulmonary fibrosis, active other malignancies, aiha or the history of allergies to similar purine analogs
boolean
C0009450 (UMLS CUI [1])
C0009566 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0426576 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
C1458140 (UMLS CUI [4,1])
C0205404 (UMLS CUI [4,2])
C0012739 (UMLS CUI [5])
C0686377 (UMLS CUI [6])
C0015967 (UMLS CUI [7])
C0206061 (UMLS CUI [8])
C0034069 (UMLS CUI [9])
C0006826 (UMLS CUI [10])
C0002880 (UMLS CUI [11])
C0020517 (UMLS CUI [12,1])
C1268902 (UMLS CUI [12,2])
Hepatitis B surface antigen positive | Hepatitis C Antibodies Positive | HIV antibody positive
Item
patients who are positive for hbs antigen, hcv antibody or hiv antibody
boolean
C0149709 (UMLS CUI [1])
C0166049 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C0920548 (UMLS CUI [3])
Granulocyte Colony-Stimulating Factor | Blood Transfusion
Item
patients who received g-csf or blood transfusion within 1 week before the screening test
boolean
C0079459 (UMLS CUI [1])
C0005841 (UMLS CUI [2])
Fludarabine phosphate Injection | Fludara | Pentostatin | Cladribine | Leustatin | SH T 586
Item
patients who had ever received previous therapy with fludarabine phosphate injection (fludara), pentostatin (coforin), cladribine (leustatin) or sh t 586
boolean
C0060483 (UMLS CUI [1,1])
C1828121 (UMLS CUI [1,2])
C0700805 (UMLS CUI [2])
C0030896 (UMLS CUI [3])
C0092801 (UMLS CUI [4])
C0701346 (UMLS CUI [5])
C1831841 (UMLS CUI [6])
Pregnancy | Childbearing Potential | Breast Feeding | Contraceptive methods Unwilling
Item
patients who are pregnant, of childbearing potential, lactating, or who do not agree to practice contraception
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0700589 (UMLS CUI [4,1])
C0558080 (UMLS CUI [4,2])